| Literature DB >> 27460082 |
Amany I Yousef1, Omar S El-Masry2, Eman H Yassin1.
Abstract
Ellagic acid (EA) has been proposed as a promising candidate for therapeutic use in colon cancer. Investigation of the effectiveness of EA in a leptin-enriched model might have been given a little interest. Here in, we investigated the anti-tumor effect of EA in the presence of leptin to reflect on therapeutic use of EA in obesity-linked colon cancer. Proven effective in leptin-enriched microenvironment, EA inhibited cell proliferation of HCT-116 and CaCo-2 cell lines, modulated cell cycle, translocated Bax to the mitochondrial fraction of cells, activated caspase-8, and reduced PCNA expression. The current study findings cast a beam of light on the potential therapeutic use of EA in obesity-related colon carcinogenesis.Entities:
Keywords: Cellular genetics; Colon; Ellagic acid; Leptin
Mesh:
Substances:
Year: 2016 PMID: 27460082 DOI: 10.1007/s13277-016-5284-7
Source DB: PubMed Journal: Tumour Biol ISSN: 1010-4283